IL0012002452 - Common Stock
NOTABLE LABS LTD
NASDAQ:NTBL (10/22/2024, 8:00:02 PM)
After market: 0.2456 0 (-0.93%)0.2479
-0.09 (-27.68%)
Notable Labs Ltd. engages in the development of predictive medicines for patients with cancer. The company is headquartered in Foster City, California and currently employs 16 full-time employees. The company went IPO on 2014-09-30. The firm has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The firm's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
NOTABLE LABS LTD
320 Hatch Drive
Foster City CALIFORNIA
P: 14158512410
Employees: 16
Website: https://notablelabs.com/
Society of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 volasertib AML program expected to begin in the coming...
Thomas Bock, MD resigns as CEO; Joseph Wagner, PhD, CSO, appointed interim CEO Company affirms plan to initiate volasertib Phase 2 program in the coming...
NTBL stock results show that Notable Labs missed analyst estimates for earnings per share the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Notable Labs (NASDAQ:NTBL) just reported results for the second quarter of 2024...
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Here you can normally see the latest stock twits on NTBL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: